SEC Form 4
Mangoceuticals, Inc. (MGRX) insider trading
In the 12 months to Oct 26, 2026, 2 MGRX insiders reported open-market sales of $174.0K across 4 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $174.0K
- 4 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
Who traded MGRX, and when
- Sale
MGRX daily close from Oct 27, 2025 to Oct 26, 2026, between $0.16 and $2.21, last $0.23. 4 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Alex P. Hamilton, Director: sold $152.9K across 1 filing, first filed Nov 26, 2025, last Nov 26, 2025. Eugene M. Johnston, CFO: sold $21.1K across 3 filings, first filed Dec 9, 2025, last Dec 17, 2025.
Largest mark · tap a row for others
Alex P. Hamilton · Director
Sale $152,875
125,000 shares at $1.22 avg
Filed Nov 26, 2025 · traded Nov 19
Close on filing date $1.07
Alex P. Hamilton · Director
Director
$152.9K soldEugene M. Johnston · CFO
CFO
$21.1K soldOpen-market trades
4 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Alex P. Hamilton | Director | $152.9K | — | 1 | — | |
| Eugene M. Johnston | CFO | $21.1K | — | 3 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Eugene M. Johnston CFO | Sale | 3,333 | $1.17 | $3.9K | 120,000 | |
traded | Eugene M. Johnston CFO | Sale | 5,000 | $1.20 | $6.0K | 123,333 | |
traded | Eugene M. Johnston CFO | Sale | 10,000 | $1.13 | $11.3K | 128,333 | |
traded | Alex P. Hamilton Director | Sale | 125,000 | $1.22 | $152.9K | 3,334 |
GET /stocks/filings/vX/form-4?tickers=MGRX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MGRX"
],
"issuer_cik": "0001938046",
"owner_cik": "0001254538",
"accession_number": "0001493152-25-028193",
"form_type": "4",
"filing_date": "2025-12-17",
"period_of_report": "2025-12-15",
"issuer_name": "MANGOCEUTICALS, INC.",
"issuer_trading_symbol": "MGRX",
"owner_name": "JOHNSTON EUGENE M",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-12-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3333,
"transaction_price_per_share": 1.1653,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 120000,
"transaction_value": 3883.9449,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"MGRX"
],
"issuer_cik": "0001938046",
"owner_cik": "0001254538",
"accession_number": "0001493152-25-027238",
"form_type": "4",
"filing_date": "2025-12-11",
"period_of_report": "2025-12-09",
"issuer_name": "MANGOCEUTICALS, INC.",
"issuer_trading_symbol": "MGRX",
"owner_name": "JOHNSTON EUGENE M",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CFO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2025-12-09",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5000,
"transaction_price_per_share": 1.195,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 123333,
"transaction_value": 5975,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "This transaction was executed in multiple trades at prices ranging from $1.19 to $1.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 10 records
- Grants and awards4 records
- Gifts6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Mangoceuticals, Inc.'s CEO sold stock?
No. Jacob D. Cohen (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is MGRX’s insider data?
These are MGRX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track MGRX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MGRX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.